Product Details
Ran-Fluoxetine
Fluoxetine HCl20 mg
Capsule
DIN/PIN/NPN
02405709
Manufacturer
Ranbaxy Pharmaceuticals Canada Inc.
Formulary Listing Date
2013-09-27
Unit Price
0.3311
Amount MOH Pays
0.3311
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Fluoxetine HCl: Because of the long half-life of the fluoxetine metabolite, steady-state concentrations occur only after 4-6 weeks. Use with caution in anorexic patients. Fluoxetine therapy should be discontinued for 5 weeks before starting irreversible monoamine oxidase inhibitors (MAOI). Similarly irreversible MAOI should be discontinued for 2 weeks before starting fluoxetine.
ATC Code
N06AB03
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02216590 | Teva-Fluoxetine | 0.3311 | 0.3311 |
| 02479494 | Sandoz Fluoxetine | 0.3311 | 0.3311 |
| 02405709 | Ran-Fluoxetine | 0.3311 | 0.3311 |
| 00636622 | Prozac | 2.4865 | 0.3311 |
| 02177587 | PMS-Fluoxetine | 0.3311 | 0.3311 |
| 02503883 | NRA-Fluoxetine | 0.3311 | 0.3311 |
| 02380579 | Mint-Fluoxetine | 0.3311 | 0.3311 |
| 02386402 | Jamp-Fluoxetine | 0.3311 | 0.3311 |
| 02374455 | Fluoxetine | 0.3311 | 0.3311 |
| 02286076 | Fluoxetine | 0.3311 | 0.3311 |
| 02242178 | Co Fluoxetine | 0.3311 | 0.3311 |
| 02448432 | Bio-Fluoxetine | 0.3311 | 0.3311 |
| 02385635 | Auro-Fluoxetine | 0.3311 | 0.3311 |
| 02216361 | Apo-Fluoxetine | 0.3311 | 0.3311 |
| 02485060 | AG-Fluoxetine | 0.3311 | 0.3311 |
| 02383241 | Ach-Fluoxetine | 0.3311 | 0.3311 |
| 02529440 | M-Fluoxetine | 0.3311 | 0.3311 |